Tag: Human Papillomavirus (HPV)
FDA Approves First Self-Test Collection Kit for HPV
AACR: At-Home HPV Testing Boosts Cervical Cancer Screening Participation
Combining self-sampling with phone-based patient navigation further increases screening participation
Disparities Seen in HPV Vaccine Uptake Among U.S. Adults
Men, Hispanic adults have lower odds of receiving the vaccine
Advantaged Households Have Lower Intent to Vaccinate Teens Against HPV
Safety concerns were primary reason for parents in the advantaged group to have no intention to vaccinate
No Increase Seen in HPV Vaccination Coverage From 2019 to 2022
Higher coverage seen for lesbian, gay, bisexual, other sexual orientation versus heterosexual women; for gay, bisexual, other versus heterosexual men
38.6 Percent of 9- to 17-Year-Olds Have Received at Least One HPV Vaccine Dose
Likelihood of receiving HPV vaccine dose higher for children with private health insurance and for those with disability
Community Cancer Centers Treating More HPV-Related Head, Neck Cancer
More patients being treated nonsurgically tied to worse survival
Direct-Mail Self-Sampling Increases Uptake of Cervical Cancer Screening
Opt-in approach with option to request a self-sampling kit minimally increases screening uptake
Methylation Score Can ID Risk for Cervical Adenocarcinomas
Methylation score had sensitivity of 74 percent, specificity of 89 percent for adenocarcinoma in situ/adenocarcinoma
Teens May Have Missed Vaccinations During COVID-19 Pandemic
Among adolescents born in 2008, vaccination coverage by age 14 years continued to lag versus earlier birth cohorts
